194
Views
5
CrossRef citations to date
0
Altmetric
Drug Profiles

The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder

&
Pages 1161-1182 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sheng-Min Wang, Changsu Han & Chi-Un Pae. (2015) Criticisms of drugs in early development for the treatment of depression: what can be improved?. Expert Opinion on Investigational Drugs 24:4, pages 445-453.
Read now

Articles from other publishers (4)

Blake R. EricksonJarrod EhrieSamuel MurrayRyan J. DoughertyMilton L. WainbergLisa B. DixonMatthew L. Goldman. (2023) A Rapid Review of “Low-Threshold” Psychiatric Medication Prescribing: Considerations for Street Medicine and Beyond. Psychiatric Services 74:3, pages 282-291.
Crossref
Xuejuan Zhang, Yongcheng Li, Zhengwei Huang, Yingtong Cui, Ziyu Zhao, Xiao Yue, Guanlin Wang, Ruifeng Liang, Ying Huang, Wen Tan & Chuanbin Wu. (2019) Development and pharmacokinetics evaluation of quetiapine fumarate sustained-release tablets based on hydrophilic matrix. Journal of Drug Delivery Science and Technology 54, pages 101322.
Crossref
Chun-Yuan Lin, Te-Jen Lai, Yu-Hsin Wu, Ping-Kun Chen, Yuan-Fu Lin & I.-Chia Chien. (2018) Change in 1-year hospitalization of overall and older patients with major depressive disorder after second-generation antipsychotics augmentation treatment. Journal of Affective Disorders 230, pages 118-124.
Crossref
Susanna Waters, Peder Svensson, Johan Kullingsjö, Henrik Pontén, Theresa Andreasson, Ylva Sunesson, Elisabeth Ljung, Clas Sonesson & Nicholas Waters. (2017) In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery. ACS Chemical Neuroscience 8:4, pages 785-797.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.